Stent graft with fenestration lock and methods of use

Information

  • Patent Grant
  • 12127931
  • Patent Number
    12,127,931
  • Date Filed
    Wednesday, February 16, 2022
    2 years ago
  • Date Issued
    Tuesday, October 29, 2024
    3 months ago
Abstract
A stent graft includes a luminal graft component defining at least one fenestration. At least one ligature traverses the fenestration and at least partially defines an opening within the fenestration that secures a branch prosthesis. The stent graft is implanted in a patient to thereby treat an arterial aneurysm, such as an aortic aneurysm in a region of the aorta that includes at least one arterial branch, including juxtarenal and short-neck aortic aneurysms.
Description
BACKGROUND

Fenestrated endovascular aortic repair (FEVAR) is a minimally invasive procedure to treat arterial aneurysms that span blood vessels that supply blood to vital organs including the kidneys, intestine and liver. Endovascular grafts employed in FEVAR define fenestrations for insertion of branch prostheses that serve as passageways for blood flow through arterial branches to vital organs following implantation of the endovascular graft. Maximizing blood flow to vital organs and minimizing endoleaks following repair of arterial aneurysms with fenestrated vascular prostheses, such as juxtarenal aortic aneurysms and short-neck abdominal aortic aneurysms, present medical challenges that must be overcome if more invasive surgical intervention is to be avoided.


Therefore, a need exits for new and improved endovascular repair devices and methods of their use to treat arterial pathologies, such as juxtarenal and short-neck abdominal aortic aneurysms.


SUMMARY

The present invention relates to stent grafts for use in treating and repairing arterial vascular damage, such as vascular damage associated with arterial aneurysms including juxtarenal aortic aneurysms and short-neck abdominal aortic aneurysms, having associated arterial branches supplying blood to vital organs and tissues.


In one embodiment, the invention is a stent graft that includes a luminal graft component having a proximal open end, a distal open end, and defining a main lumen extending from the proximal open end to the distal open end. The luminal graft component defines at least one fenestration. At least one ligature traverses the at least one fenestration, wherein the ligature, along or in combination with the luminal graft component, constitutes a fenestration lock at the fenestration, whereby a branch prosthesis can be secured by the fenestration lock.


In another embodiment, the invention is a method for treating an arterial aneurysm that includes delivering a stent graft through an artery to an aneurysm of a patient, the aneurysm spanning a region of an artery that spans an associated arterial branch. The stent graft includes a luminal graft component having a proximal open end, a distal open end, and a main lumen extending from the proximal open end to the distal open end, and wherein the luminal graft component defines at least one fenestration. At least one ligature traverses the fenestration, the ligature alone or in combination with the luminal graft component, constitutes a fenestration lock at the fenestration, whereby a proximal end or a distal end of a branch prosthesis can be secured by the fenestration lock. The fenestration is substantially aligned with the associated arterial branch at the aneurysm site of the patient and then the stent graft is at least partially released from a delivery device. At least one branch prosthesis is delivered through the proximal open end or the distal open end of the luminal graft component of the stent graft, and through the opening and to the associated arterial branch, thereby treating the arterial aneurysm.


The vascular prostheses of the invention have several advantages by, for example, providing the surgeon with increased flexibility to accommodate anatomical variations in the size of arterial branches at an aneurysm. Specifically, the fenestration lock in a luminal graft can better secure a branch prosthesis during implantation. The vascular prostheses of the invention also have the additional advantage of improving a seal between a fenestration of the stent graft of the invention and a branch prosthesis by limiting motion of the branch prostheses, following insertion of the branch prosthesis through the fenestration, thereby significantly reducing the incidence and severity of endoleaks and resulting complications.





BRIEF DESCRIPTION OF THE DRAWINGS

The foregoing will be apparent from the following more particular description of example embodiments, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating embodiments.



FIG. 1A is a side view of one embodiment of a stent graft of the invention.



FIG. 1B is a detail of a fenestration lock of the stent graft of FIG. 1A.



FIG. 2 is a side view of a fenestration lock of another embodiment of a stent graft of the invention.



FIG. 3 is a perspective view of a fenestration ring that can be included as a component of a stent graft of the invention.



FIG. 4 is a side view of a fenestration lock of another embodiment of a stent graft of the invention.



FIG. 5 is a side view of a fenestration lock of a further embodiment of a stent graft of the invention.



FIG. 6 is a side view of a fenestration lock of yet another embodiment of a stent graft of the invention.



FIG. 7 is a side view of a fenestration lock of an additional embodiment of a stent graft of the invention.



FIG. 8 is a side view of a fenestration lock of still another embodiment of a stent graft of the invention.



FIG. 9 is an exploded side view of one embodiment of a stent graft assembly of the invention.



FIG. 10 is a side view of the assembled stent graft of the invention and (prior art) branch prosthesis of FIG. 9, following delivery through the fenestration lock of the branch prosthesis.



FIG. 11 is an exploded view of one embodiment of a (prior art) delivery device for use in implanting a stent graft of the invention.



FIG. 12A is a side view of the delivery device of FIG. 11, and containing a stent graft of the invention (not shown) loaded within an introducer sheath of the delivery device.



FIG. 12B is a side view of the delivery device of FIG. 12A, following retraction of an introducer sheath component of the delivery device to expose a stent graft of the invention or a branch prosthesis during delivery to an aneurysm site.



FIG. 12C is a side view of the delivery device and the stent graft of FIG. 12B after retraction of the delivery device from the stent graft of the invention or the branch prosthesis, thereby completing implantation of the prosthesis following removal of the delivery device from the stent graft.



FIG. 13A is a side view of another embodiment of the stent graft of the invention after implantation at an aneurysm site of a patient.



FIG. 13B is a detail of a fenestration lock of the stent graft of FIG. 13A.



FIG. 14 is a side view of the implanted stent graft of FIG. 13A following implantation of a branch prostheses.





DETAILED DESCRIPTION OF THE INVENTION

The invention is generally directed to stent graft and methods for treating and repairing aortic vascular damage, such as vascular damage associated with an aortic aneurysm in regions of the aorta having arterial branches to vital organs and tissues, such as juxtarenal aortic aneurysms and short-neck abdominal aortic aneurysms.


The features and other details of the invention, either as steps of the invention or as combinations of parts of the invention will now be more particularly described and pointed out in the claims. It will be understood that the particular embodiments of the invention are shown by way of illustration and not as limitations of the invention. The principle features of this invention can be employed in various embodiments without departing from the scope of the invention.


A description of example embodiments of the invention follows.


When reference is made herein to a prosthesis, also referred to herein as a “stent graft,” “stent graft prosthesis,” or “stent graft,” to be delivered, or implanted in a patient, the word “proximal” means that portion of the prosthesis or component of the prosthesis that is relatively close to the heart of the patient and “distal” means that portion of the prosthesis or component of the prosthesis that is relatively far from the heart of the patient. A “longitudinal axis,” as that term is defined herein, means an axis along a lengthwise direction of a body that also passes through a center of gravity of the body.


When, however, reference is made to a delivery system or a component of a delivery system employed to deliver, or implant, a prosthesis, the word, “proximal,” as employed herein, means closer to the clinician using the delivery system. When reference is made to a delivery system or a component of a delivery system, “distal,” as that term is employed herein, means, further away from the clinician using the delivery system.


For clarity, the word “proximate” means “close to,” as opposed to the meanings ascribed to “proximal” or “distal” described above with respect to either the prosthesis or a delivery system.


In an embodiment, the stent graft is shown in FIG. 1A. Stent graft 10 includes luminal graft component 12 having proximal open end 14, distal open end 16, and defining lumen 18 extending from the proximal open end 14 to distal open end 16. Luminal graft component 12 defining at least one fenestration 20. Luminal graft component 12 is made from a suitable material, such as is known to one of skill in the art, including, for example, polytetrafluoroethylene (PTFE), such as ePTFE, and polyethylene terephthate (PET), such as woven polyester.


Ligatures 22 traverse fenestration 20 of luminal graft component 12 to thereby at least partially define opening 24, within fenestration 20. As shown later, a branch prosthesis can be secured within fenestration 20 by plurality of ligatures 22, ligatures 22 and a portion of the periphery of fenestration 20 thereby constituting a fenestration lock. Ligatures 22 are affixed to luminal graft component 12 and fenestration 20 by a suitable method, such as is known to those skilled in the art. Examples of a suitable method include use of sutures or a biocompatible adhesive. Ligatures 22 are fabricated of a suitable material such as is known in the art, including, for example, at least one member selected from the group consisting of sutures, cloth, metal, and an elastic material, such as a biocompatible rubber band or latex. Examples of suitable sutures include sutures fabricated of at least one member of the group consisting of PTFE, ePTFE, polyglycolic acid, polylactic acid, monocryl and polydioxane, non-absorbable nylon, polyester, polyvinylidene difluoride (PVDF) and polypropylene. Suitable rubber bands can include, for example, rubber bands formed of natural rubber or a synthetic rubber. Metal can include wires, such as an elastic material or shape memory alloy. Metal ligatures can include a shape memory alloy, such as nitinol, and stainless steel.


Optionally, stent graft 10 includes radially expanding bare stent 26 having proximal apices 28 and distal apices 30. Proximal apices 28 extend proximally beyond proximal open end 14 of luminal graft component 12. In an embodiment, proximal apices 28 include a fixation component, such as at least one barb 27. Distal apices 30 of bare stent 26 are fixed to proximal open end 14 of luminal graft component 12.


Suitable radiopaque markers 32, such as those known to those skilled in the art, are secured, such as by suturing or use of biocompatible adhesive, to at least one of proximal open end 14, distal open end 16, the perimeter of fenestration 20 of luminal graft component 12, and fenestration lock 24, which is constituted by ligatures 22 and a portion of the perimeter of fenestration 20. Radiopaque markers 32, in one embodiment, are incorporated into ligatures 22. In an embodiment, ligatures 22, radiopaque markers 32 and ring 36 (described in detail below) include a radiopaque material, such as at least one radiopacifier selected from the group consisting of barium sulfate, bismuth, tungsten, platinum, platinum-iridium, tantalum and tantalum-tungsten.


Stent graft 10 includes plurality of stents 34 distributed longitudinally along luminal graft component 12. Stents 34 are formed from a suitable material, such as is known to those skilled in the art, including, for example, stainless steel or a shape-memory alloy, such as Nitinol. Stents 34 are fixed to luminal graft component by suitable means known to those skilled in the art, such as by suturing or affixation by employment of biocompatible adhesive.


As shown in detail in FIG. 1B, ligatures 22 of stent graft 10 are substantially parallel to each other. Ligatures 22 are secured at one or more points to luminal graft component 12 at perimeter of fenestration 20 by one or more suitable methods, such as is known to one of skill in the art. Examples of such suitable methods include suturing along intermittent or continuous lengths (not shown), or along the entire length of the perimeter of fenestration 20 to thereby constitute fenestration lock 24. Suitable suture materials for securing plurality of sutures include sutures fabricated of PTFE, ePTFE, polyglycolic acid, polylactic acid, monocryl and polydioxane, non-absorbable nylon, polyester, polyvinylidene difluoride (PVDF) and polypropylene, staples, biocompatible adhesive, or other suitable material as is known to one skilled in the art. As shown in FIG. 2, in another embodiment, a stent graft defines fenestration 21 and includes ligatures 23 that are substantially parallel to each other and ligatures 25 that are substantially perpendicular to the substantially parallel ligatures 22, to thereby constitute fenestration lock 27. Alternative embodiments of a fenestration lock of the stent graft of the invention are shown in FIGS. 4, 5, 6, 7, and 8, that include examples of suitable ligature configurations 29a, 29b, 29c, 29d, and 29e, respectively. Each of ligature configurations 29a, 29b, 29c, 29d, and 29e constitutes an example of a fenestration lock.


Returning to FIG. 2, the periphery of fenestration 20 can be encompassed by ring 36, which extends about the perimeter of fenestration 20. In one embodiment, ring 36 is a self-expanding stent, and is formed of a suitable material, such as stainless steel, a suitable polymer, or a shape memory alloy, such as Nitinol. In one embodiment, shown in FIG. 3, ring 36 includes main component 38 that defines ends 40, 42 that are linked by connecting component 44 that is fixed or slideably engaged with either or both ends. Examples of suitable rings are further described in “Vascular Prosthesis with Moveable Fenestration and Method of Use,” filed Feb. 23, 2018; by Samuel Arbefeuille, the teachings of which are incorporated herein by reference in their entirety.



FIG. 9 is an exploded side view of a stent graft assembly 46 of the invention, including stent graft 10, as represented in FIG. 1A, and a suitable branch prosthesis 48. Branch prosthesis 48 includes proximal end 50, distal end 52, luminal graft component 54 defining a lumen, and stents 58 extending along luminal graft component 54. FIG. 10 is a side view of assembled stent graft assembly 46 shown in FIG. 9, following delivery of branch prosthesis through fenestration lock 24 of stent graft 10. Distal end 52 of branch prosthesis 48 is positioned through fenestration lock 24 which is constituted, at least in part, of ligatures 22 or, alternatively by ligatures 22 and a portion of periphery of fenestration 20, as shown in FIG. 1B. Fenestration lock 24 locks branch prosthesis 48 upon implantation of branch prosthesis 48 within fenestration lock 24, such as by at least one of reversible or elastic accommodation of a diameter of branch prosthesis 48, or by constriction of branch prosthesis 48 during radial expansion of branch prosthesis 48 after delivery through fenestration lock.



FIG. 11 is an exploded side view of a prior art delivery device suitable for delivering a stent graft of the invention. As can be seen in FIG. 11, prior art delivery device 70 includes guidewire catheter 72 having proximal end 74 and distal end 76. Proximal handle 78 is fixed to proximal end 74 and nose cone 80 is fixed to distal end 76. Introducer sheath 82 has proximal end 84 and distal end 86. Distal handle 88 is fixed to proximal end 84. Introducer sheath 82 can be rigid or flexible.



FIG. 12A is a side view of the prior art delivery device 70 when assembled and loaded with a stent graft of the invention. As can be seen therein, introducer sheath 82 and distal handle 88 extend around guidewire catheter 72. Although not shown, stent graft 10 of the invention is held in a radially constricted position around guidewire catheter 72 and within introducer sheath 82. In a method of the invention, stent graft 90 is implanted at aneurysm 93 by advancing delivery device 70 within an artery of a patient until stent graft 70 spans aneurysm 93. As can be seen in the embodiment shown in FIGS. 12A through 12C, with reference to FIG. 12B, distal handle 88 is then retracted in the direction of arrow 87 along guidewire catheter 72 and toward proximal handle 78, thereby retracting introducer sheath 82 from around stent graft 90 with at least one fenestration 91. In another embodiment, not shown, delivery device 70 can be advanced in an artery until introducer sheath 82 and stent graft 90 within introducer sheath 82 are distal to aneurysm 93, whereby proximal handle 98 and stent graft 90, which is attached to guidewire catheter 72, are advanced in the direction of arrow 89 to thereby direct stent graft 90 from introducer sheath 82 and span aneurysm 93. Stent graft 70 is released from its constricted position, and radially expands to a released position, such as by use of a balloon catheter, or by use self-expanding radial stents, as is known in the art, and is thereby deployed at the aneurysm site. Delivery device 70 thereafter is removed from the patient, as shown in FIG. 12C, thereby completing implantation of the stent graft and treatment of the aortic aneurysm. The same or a similar delivery device can be employed to deliver or implant proximal end branch prosthesis 95 through fenestration 91 of stent graft 90 of the invention and distal end of branch prosthesis into arterial branch 96. It is to be understood that, alternatively, other suitable types of aortic prosthesis delivery devices, such as are known in the art, can be employed.


In another embodiment of a method of the invention, described with reference to FIG. 13A, stent graft 100 is delivered by use of a suitable delivery device, as described above, through artery 102 to aneurysm 104 spanning a region of aorta 102 that includes at least one arterial branch, such as at least one of celiac artery 106, superior mesenteric artery 108, right renal artery 110 and left renal artery 112. Stent graft 100 is radially and releasably constrained by a suitable stent graft delivery device, as shown in FIG. 12A. FIG. 13B, which is a detail of fenestration 114 of FIG. 13A, shows plurality of ligatures 121, 123 of fenestration 114 that is encompassed by ring 136. As shown in FIG. 13B, plurality of ligatures 121, 123 span fenestration 114 to thereby constitute fenestration lock 125. Stent graft 100 is rotated about a longitudinal axis to approximately align fenestrations 114, 116, 118, 120 with corresponding arterial branches 106, 108, 110, 112 of aorta 102 at aneurysm site 104. Stent graft 100 is then released from stent graft delivery device.


Stent graft 100 includes luminal graft component 130 that has proximal end opening 132, distal end opening 134, and defines main lumen 139.


Each branch prosthesis 124, 126, 128, 130 is delivered by a respective branch prosthesis delivery device, such as shown in FIGS. 11 and 12A through 12C through proximal opening 132 or distal opening 134 into the main lumen 139 of the luminal graft component 130, as shown in FIG. 14. A distal end of each of branch prosthesis 122, 124, 126, 128 is then delivered through respective fenestration lock 137, 138, 140, 142 at each respective fenestration 114, 116, 118, 120 and into the respective branch 106, 108, 110, 112 of the aorta and secured therein. Each branch prosthesis 122, 124, 126, 128 is then released from the respective branch prosthesis delivery device, and each branch prosthesis 122, 124, 126, 128 expands radially from a constricted position to an expanded position, such as by use of a suitable balloon catheter, or a self-expanding radial stents at the stent graft. Expansion of each branch prosthesis, 122, 124, 126, 128 at each respective opening presses against the ligatures that define each fenestration lock 137, 138, 140, 142, thereby locking the proximal end of each branch prosthesis at the respective fenestration lock. Stent graft 100 is then removed from the patient, thereby completing implantation and treatment of the aortic aneurysm. In an embodiment, additional branch prosthesis 141 can be implanted into distal end of vascular prostheses of the invention.


Although not shown, the distal end of the vascular prostheses of the invention can be bifurcated and additional branch prostheses can be implanted into the distal end of the bifurcated stent graft.


Vascular prostheses of the invention can be implanted, for example, by transfemoral access. Additional vascular repair devices that are directed into the vascular prostheses of the invention can be implanted, for example, by supraaortic vessel access (e.g., through the brachial artery), or by transfemoral access or access from some other branch or branches of major blood vessels including peripheral blood vessels.


The teachings of all patents, published applications and references cited herein are incorporated by reference in their entirety. The relevant teachings of U.S. Pat. Nos. 8,292,943; 7,763,063; 8,308,790; 8,070,790; 8,740,963; 8,007,605; 9,320,631; 8,062,349; 9,198,786; 8,062,345; 9,561,124; 9,173,755; 8,449,595; 8,636,788; 9,333,104; 9,408,734; 9,408,735; 8,500,792; 9,220,617; 9,364,314; 9,101,506; 8,998,970; 9,554,929; 9,439,751; 9,592,112; 9,655,712, 9,827,123, 9,877,857, 9,907,686; U.S. patent application Ser. Nos. 14/575,673; 15/166,818; 15/167,055; 14/272,818; 14/861,479; 15/478,424; 15/478,737; 15/587,664; 15/604,032; 15/672,404; 15/816,772; 15/839,272; 15/417,467; PCT/US2017/025844; PCT/US2017/025849; PCT/US52017/025912; PCT/US2017/034223 and PCT/US2017/046062, are also incorporated by reference in their entirety.


The relevant teachings of International Application Ser. Nos.: PCT/US20189/019355; PCT/US2018/019344; PCT/US2018/019349; PCT/US2018/019353; PCT/US2018/019354; PCT/US2018/019342; PCT/US2018/019350; PCT/US2018/019356; PCT/US2018/019351; and PCT/US2018/019510, are also incorporated by reference in their entirety.


While example embodiments have been particularly shown and described, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the embodiments encompassed by the appended claims.

Claims
  • 1. A method for treating an arterial aneurysm, comprising the steps of: a) delivering a stent graft through an artery to an aneurysm of a patient, the aneurysm spanning a region of the artery that includes at least one arterial branch, the stent graft including: i) a luminal graft component having a proximal open end, a distal open end, and defining a main lumen extending from the proximal open end to the distal open end, the luminal graft component defining at least one fenestration, andii) at least one ligature traversing the at least one fenestration, the at least one ligature, alone or in combination with the luminal graft component, constituting a fenestration lock at the at least one fenestration, whereby a branch prosthesis can be secured by the fenestration lock;iii) at least one fenestration ring encompassing the at least one fenestration and fixed to the luminal graft component, the at least one fenestration ring defining a variable fenestration ring diameter, wherein the fenestration ring diameter can expand upon insertion of a branch prosthesis through the at least one fenestration ring during implantation of the branch prosthesis;b) substantially aligning the fenestration with the arterial branch at the aneurysm site of the patient; andc) delivering a branch prosthesis through the proximal open end or the distal open end of the luminal graft component of the stent graft, and through the fenestration lock to the associated arterial branch, thereby treating the arterial aneurysm.
  • 2. The method of claim 1, wherein a first ligature intersects a second ligature within the opening of the fenestration.
  • 3. The method of claim 1, wherein the at the at least one ligature is at least one member selected from the group consisting of sutures, rubber bands, latex, cloth, and metal.
  • 4. The method of claim 1, wherein the at least one ligature includes an elastic material.
  • 5. The method of claim 1, wherein the at least one ligature includes a shape memory alloy.
  • 6. The method of claim 5, wherein the shape memory alloy is Nitinol.
  • 7. The method of claim 1, wherein the at least one ligature includes at least two ligatures that are substantially parallel to each other.
  • 8. The method of claim 1, wherein the at least one ligature is a plurality of ligatures that includes ligatures that are substantially parallel to each other and ligatures that are substantially perpendicular to the substantially parallel ligatures.
  • 9. The method of claim 1, wherein the at least one ligature is a plurality of ligatures that completely form the fenestration lock.
RELATED APPLICATIONS

This application is a divisional of U.S. patent application Ser. No. 16/392,443 filed on Apr. 23, 2019, which is a continuation of International Patent Application No. PCT/US2018/019352, which designated the United States and was filed on Feb. 23, 2018, published in English, which claims the benefit of U.S. Provisional Application No. 62/463,054, filed on Feb. 24, 2017. The entire teachings of the above applications are incorporated herein by reference in their entirety.

US Referenced Citations (199)
Number Name Date Kind
4787391 Elefteriades Nov 1988 A
5123917 Lee Jun 1992 A
5242452 Inoue Sep 1993 A
5507769 Marin et al. Apr 1996 A
5713948 Uflacker Feb 1998 A
5755769 Richard et al. May 1998 A
5873906 Lau et al. Feb 1999 A
6113623 Sgro Sep 2000 A
6171334 Cox Jan 2001 B1
6280464 Hayashi Aug 2001 B1
6352561 Leopold et al. Mar 2002 B1
6395018 Castaneda May 2002 B1
6610087 Zarbatany et al. Aug 2003 B1
6645242 Quinn Nov 2003 B1
6776791 Stallings et al. Aug 2004 B1
7112216 Gregorich Sep 2006 B2
7189257 Schmitt et al. Mar 2007 B2
7435253 Hartley et al. Oct 2008 B1
7637940 Kocur et al. Dec 2009 B2
7645298 Hartley et al. Jan 2010 B2
7763063 Arbefeuille et al. Jul 2010 B2
7842081 Yadin Nov 2010 B2
8007605 Arbefeuille et al. Aug 2011 B2
8062345 Ouellette et al. Nov 2011 B2
8062346 Quigley et al. Nov 2011 B2
8062349 Moore et al. Nov 2011 B2
8070790 Berra et al. Dec 2011 B2
8128686 Paul, Jr. et al. Mar 2012 B2
8172895 Anderson et al. May 2012 B2
8277501 Chalekian et al. Oct 2012 B2
8292943 Berra et al. Oct 2012 B2
8298278 Gregorich et al. Oct 2012 B2
8308790 Arbefeuille et al. Nov 2012 B2
8333800 Bruszewski et al. Dec 2012 B2
8343211 Gregorich et al. Jan 2013 B2
8377113 Hartley et al. Feb 2013 B2
8449595 Ouellette et al. May 2013 B2
8470018 Hartley et al. Jun 2013 B2
8480725 Rasmussen et al. Jul 2013 B2
8480728 Gregorich et al. Jul 2013 B2
8486129 Lautherjung Jul 2013 B2
8500792 Berra Aug 2013 B2
8506622 Bruszewski et al. Aug 2013 B2
8636788 Arbefeuille et al. Jan 2014 B2
8641752 Holm et al. Feb 2014 B1
8740963 Arbefeuille et al. Jun 2014 B2
8764812 Mayberry et al. Jul 2014 B2
8808351 Osborne Aug 2014 B2
8915955 West et al. Dec 2014 B2
8926693 Duffy et al. Jan 2015 B2
9101506 Arbefeuille et al. Aug 2015 B2
9173755 Berra et al. Nov 2015 B2
9198786 Moore et al. Dec 2015 B2
9220617 Berra Dec 2015 B2
9259336 Schaeffer et al. Feb 2016 B2
9320631 Moore et al. Apr 2016 B2
9333104 Ouellette et al. May 2016 B2
9358142 Johnson Jun 2016 B2
9364314 Berra et al. Jun 2016 B2
9375308 Norris Jun 2016 B2
9408734 Arbefeuille et al. Aug 2016 B2
9408735 Arbefeuille et al. Aug 2016 B2
9439751 White et al. Sep 2016 B2
9561124 Arbefeuille et al. Feb 2017 B2
9592112 Arbefeuille et al. Mar 2017 B2
9655712 Berra et al. May 2017 B2
9770322 Burkart et al. Sep 2017 B2
9827123 Arbefeuille et al. Nov 2017 B2
9839542 Bruszewski et al. Dec 2017 B2
9855130 Roeder et al. Jan 2018 B2
9861503 Barthold et al. Jan 2018 B2
9877857 Arbefeuille et al. Jan 2018 B2
9907686 Ouellette et al. Mar 2018 B2
9913743 Arbefeuille et al. Mar 2018 B2
9925080 Arbefeuille et al. Mar 2018 B2
10004620 Treacy et al. Jun 2018 B2
10005269 Hall et al. Jun 2018 B2
10080674 Yuan et al. Sep 2018 B2
10105248 Berra et al. Oct 2018 B2
10245137 Scutti et al. Apr 2019 B2
10265202 Greenberg et al. Apr 2019 B2
10390930 Arbefeuille et al. Aug 2019 B2
10485684 Marmur et al. Nov 2019 B2
10512556 Longo et al. Dec 2019 B2
10617542 Chakfe et al. Apr 2020 B2
10702406 Swift et al. Jul 2020 B2
10744012 Bonsignore et al. Aug 2020 B2
10898357 Arbefeuille et al. Jan 2021 B2
10987235 Eubanks et al. Apr 2021 B2
10987873 Moldave et al. Apr 2021 B2
11000359 Torrance et al. May 2021 B2
11278390 Lostetter Mar 2022 B2
11291572 Garcia Apr 2022 B2
11351025 Lostetter Jun 2022 B2
11369466 Arbefeuille Jun 2022 B2
11399929 Arbefeuille Aug 2022 B2
11413177 Lostetter Aug 2022 B2
11547584 Lostetter Jan 2023 B2
11779454 Arbefeuille Oct 2023 B2
11801129 Lostetter Oct 2023 B2
20020062133 Gilson et al. May 2002 A1
20020177890 Lenker Nov 2002 A1
20020188344 Bolea et al. Dec 2002 A1
20020193872 Trout et al. Dec 2002 A1
20040059406 Cully et al. Mar 2004 A1
20040073289 Hartley Apr 2004 A1
20040138737 Davidson et al. Jul 2004 A1
20050102021 Osborne May 2005 A1
20050102023 Yadin et al. May 2005 A1
20050119722 Styrc et al. Jun 2005 A1
20050131518 Hartley et al. Jun 2005 A1
20050131519 Hartley Jun 2005 A1
20050131523 Bashiri et al. Jun 2005 A1
20050171597 Boatman et al. Aug 2005 A1
20060015171 Armstrong Jan 2006 A1
20060095118 Hartley May 2006 A1
20060155359 Watson Jul 2006 A1
20060184226 Austin Aug 2006 A1
20060247760 Ganesan et al. Nov 2006 A1
20060247761 Greenberg et al. Nov 2006 A1
20070021822 Boatman Jan 2007 A1
20070055358 Krolik et al. Mar 2007 A1
20070055360 Hanson et al. Mar 2007 A1
20070112418 Eidenschink et al. May 2007 A1
20070135904 Eidenschink et al. Jun 2007 A1
20070208414 Sorenson et al. Sep 2007 A1
20070208419 Meyer et al. Sep 2007 A1
20070213805 Schaeffer et al. Sep 2007 A1
20070244542 Greenan et al. Oct 2007 A1
20080091260 Pomeranz et al. Apr 2008 A1
20080132988 Jordan Jun 2008 A1
20080269867 Johnson Oct 2008 A1
20090030502 Sun et al. Jan 2009 A1
20090043377 Greenberg et al. Feb 2009 A1
20090048663 Greenberg Feb 2009 A1
20090248135 Bruszewski et al. Oct 2009 A1
20100057186 West et al. Mar 2010 A1
20100063576 Schaeffer et al. Mar 2010 A1
20100234932 Arbefeuille et al. Sep 2010 A1
20100316830 Hartley et al. Dec 2010 A1
20110190862 Bashiri et al. Aug 2011 A1
20110270378 Bruszewski et al. Nov 2011 A1
20120022630 Wubbeling Jan 2012 A1
20120035714 Ducke et al. Feb 2012 A1
20120191174 Vinluan et al. Jul 2012 A1
20120221096 Roeder et al. Aug 2012 A1
20120271401 Bruszewski et al. Oct 2012 A1
20120296360 Norris et al. Nov 2012 A1
20130116773 Roeder et al. May 2013 A1
20130116775 Roeder et al. May 2013 A1
20130184806 Arbefeuille et al. Jul 2013 A1
20130211505 Robison Aug 2013 A1
20130282102 Peterson Oct 2013 A1
20130289696 Maggard et al. Oct 2013 A1
20130289713 Pearson Oct 2013 A1
20140039597 Arbefeuille et al. Feb 2014 A9
20140046428 Cragg et al. Feb 2014 A1
20150105819 Becking et al. Apr 2015 A1
20150105850 Shahriari Apr 2015 A1
20150202065 Shalev et al. Jul 2015 A1
20150216686 Chakfe et al. Aug 2015 A1
20150272755 Arbefeuille et al. Oct 2015 A1
20150335452 Rao et al. Nov 2015 A1
20160100969 Lesmeister et al. Apr 2016 A1
20160106564 Roeder et al. Apr 2016 A1
20160184078 Choubey et al. Jun 2016 A1
20160199207 Treacy et al. Jul 2016 A1
20160302950 Marmur et al. Oct 2016 A1
20170135807 Arbefeuille et al. May 2017 A1
20170281382 Lostetter et al. Oct 2017 A1
20180071123 Arbefeuille et al. Mar 2018 A1
20180153680 Greenberg et al. Jun 2018 A1
20180296374 Chakfe et al. Oct 2018 A1
20190231514 Arbefeuille Aug 2019 A1
20190231568 Garcia Aug 2019 A1
20190231571 Lostetter Aug 2019 A1
20190247178 Arbefeuille Aug 2019 A1
20190247179 Lostetter Aug 2019 A1
20190247213 Lostetter Aug 2019 A1
20190269497 Arbefeuille Sep 2019 A1
20190269498 Arbefeuille et al. Sep 2019 A1
20190269537 Arbefeuille Sep 2019 A1
20190282355 Lostetter Sep 2019 A1
20190321207 Arbefeuille et al. Oct 2019 A1
20190328556 Eubanks et al. Oct 2019 A1
20190350694 Arbefeuille et al. Nov 2019 A1
20200246165 Arbefeuille et al. Aug 2020 A1
20200352700 Torrance et al. Nov 2020 A1
20210100669 Arbefeuille et al. Apr 2021 A1
20210236262 Torrance et al. Aug 2021 A1
20220087841 Arbefeuille Mar 2022 A1
20220168091 Lostetter Jun 2022 A1
20220257361 Lostetter Aug 2022 A1
20220304798 Arbefeuille Sep 2022 A1
20220313419 Arbefeuille Oct 2022 A1
20220378594 Lostetter Dec 2022 A1
20220395365 Lostetter et al. Dec 2022 A1
20230063108 Magen et al. Mar 2023 A1
20240058114 Arbefeuille Feb 2024 A1
Foreign Referenced Citations (44)
Number Date Country
105832447 Aug 2016 CN
1673040 Jun 2006 EP
1847234 Oct 2007 EP
1847236 Oct 2007 EP
2471498 Jul 2012 EP
2517672 Oct 2012 EP
2735283 May 2014 EP
2740440 Jun 2014 EP
2745812 Jun 2014 EP
2745813 Jun 2014 EP
2749250 Jul 2014 EP
2749251 Jul 2014 EP
2606851 Nov 2015 EP
3040054 Jul 2016 EP
3068339 Sep 2016 EP
3078349 Oct 2016 EP
3146993 Mar 2017 EP
3272319 Jan 2018 EP
3042702 Apr 2017 FR
2464978 May 2010 GB
2012152549 Aug 2012 JP
WO-9703624 Feb 1997 WO
WO-9748350 Dec 1997 WO
WO-9929262 Jun 1999 WO
WO-9934749 Jul 1999 WO
WO-0160285 Aug 2001 WO
WO-03099108 Dec 2003 WO
WO-2005034809 Apr 2005 WO
WO-2005034810 Apr 2005 WO
WO-2009148594 Dec 2009 WO
WO-2010024867 Mar 2010 WO
WO-2010024880 Mar 2010 WO
WO-2010030370 Mar 2010 WO
WO-2010127040 Nov 2010 WO
WO-2012116368 Aug 2012 WO
WO-2014149022 Sep 2014 WO
WO-2015070792 May 2015 WO
WO-2016122862 Aug 2016 WO
WO-2018026768 Feb 2018 WO
WO-2018156849 Aug 2018 WO
WO-2018156850 Aug 2018 WO
WO-2022265985 Dec 2022 WO
WO-2022265989 Dec 2022 WO
WO-20220265989 Dec 2022 WO
Non-Patent Literature Citations (5)
Entry
International Preliminary Report on Patentability for International Application No. PCT/US2018/019352 dated Aug. 27, 2019.
International Search Report and Written Opinion for International Application No. PCT/US2018/019352 dated May 7, 2018.
International Search Report and Written Opinion for Application No. PCT/US2022/033239 Nov. 7, 2022.
International Search Report and Written Opinion for International Application No. PCT/US22/33247 dated Sep. 13, 2022.
Wang et al. “Preliminary experimental study on a novel adjustable sutureless aortic prosthesis” Chinese Journal of Experimental Surgery, 23(11): 1325-1327 w/ English Abstract (2006).
Related Publications (1)
Number Date Country
20220168091 A1 Jun 2022 US
Provisional Applications (1)
Number Date Country
62463054 Feb 2017 US
Divisions (1)
Number Date Country
Parent 16392443 Apr 2019 US
Child 17673147 US
Continuations (1)
Number Date Country
Parent PCT/US2018/019352 Feb 2018 WO
Child 16392443 US